Tivic hits enrolment target for vagus nerve stimulation trial
Tivic has not yet identified clinical targets as the company optimises its non-invasive technology.
Medical Devices
Intelligent gears up for FDA approval of fingerprint drug detection device
Sinaptica’s neuromodulation device aces Phase II Alzheimer’s trial
Nexalin trials Halo neurostimulation device in traumatic brain injury
Mixed results for Nexalin’s transcranial alternating current stimulation trial
Adaptive deep brain stimulation trial results poised to “transform” Parkinson’s disease
SetPoint’s neuromodulation implant wins IDE for multiple sclerosis study
Synchron’s BCI meets primary endpoint in feasibility trial
